Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ergonomical Assessment of Three-Dimensional Versus Two-Dimensional Thoracoscopic Lobectomy for Lung Cancer

NCT03925103 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.

NCT NCT03925103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03925103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ergonomical Assessment of Three-Dimensional Versus Two-Dimensional Thoracoscopic Lobectomy for Lung Cancer
Lead sponsor
University of Rome Tor Vergata
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2018
Completion date
December 31, 2019
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early stage non-small-cell lung cancer (stage 1-2)